|
Registration for the 2013 Duke Bioinformatics Workshop is now open. Information is available on the Workshop Webpage.
Learn about current studies at the monthly CHG Research Conference
-
The Duke Cancer Institute and the Duke Epigenetics and Epigenomics Program present a mini symposium on Monday, April 29th. For more information, click here.
-
Dr. Simon Gregory Ph.D. was awarded a grant to investigate the function that a gene may play in immune responses and how this may contribute to susceptibility to Multiple Sclerosis. Hear Dr. Gregory talk about his research in this video interview.
-
The Duke Center for Human Genetics will be hosting a Gospel Concert to benefit Autism Research on Saturday, October 27th from 1 - 4 PM. Please view the flyer for more information.
-
Dr. Simon Gregory will lead his team at the CHG in examining samples collected from the recently funded ACE SOARS Network project by looking at how non-DNA based variation predicts response to treatment and the types of genes that are produced during treatment for Autism spectrum disorders. For more information, read here here or here to read more about this NIH funded study.
-
Faculty member Simon Gregory has received a 2012 Medical Education Award from the Duke Department of Medicine. Read about the award in Medicine News.
-
Faculty member Michelle Winn and Rasheed Gbadegesin were authors on a paper which was chosen as one of two "Best Basic Science Research" papers of 2011 by the Duke Department of Medicine. A paper authored by faculty member Svati Shah was awarded the "Best Translational Science Research" paper of 2011. Read about their research here.
-
Svati Shah, MD, a CHG Faculty Member and assistant professor of medicine in Cardiology, received the Judson Daland Prize for Outstanding Achievement in Clinical Investigation from the American Philosophical Society.
-
Metabolomics research yields a chemical fingerprint that Duke researchers hope will provide reliable indicators of heart disease and diabetes. Read about how current studies at the CHG and Duke are working to make this a reality.
-
Researchers at Duke University Medical Center have pinpointed a common gene variant in blacks that may be associated with the development of life-threatening heart arrhythmias. The finding may help determine which patients are likely to benefit most from implantable cardio-defibrillators (ICDs). The study includes patients from a Duke Electrophysiology Genetic and Genomic Study biorepository developed by CHG faculty member Svati Shah. Read more about the study here.
-
The American Society for Clinical Investigation (ASCI) inducted four researchers from Duke University Medical Center out of the field of 70 2011 winners, including CHG faculty member Michelle Winn, MD. Dr Winn works to learn more about the genetic basis of hereditary focal and segmental glomerulosclerosis (FSGS) and her team recently discovered the transient receptor potential cation channel, type 6 (TRPC6) as a cause for hereditary FSGS.
-
Dr. Svati Shah, a CHG faculty member, is part of team to looking to discover metabolic predictors for diabetes. Read more here.
-
CHG researcher Allison-Ashley-Koch and Genetic Counselor Heidi Cope aim to identify the genetic links in Anencephaly. Two recent articles appeared in the Raleigh News and Observer: Diet rich in folic acid greatly reduces defect's chances and The struggles of a couple whose baby will not survive Anencephaly
-
Research by Dr. Simon Gregory on epigentic markers and autism as highlighted in a recent NY Times article.
-
Dr. Svati Shah is showcased in the August Duke Global Health Institute's Faces of Global Health.
Goldie Byrd, a research adjunct faculty member in the Duke Department of Medicine, discusses her research on Alzheimer Disease in the African-American population. Read the article here.
-
CHG researchers have identified a new genetic signature that is strongly associated with autism. The research targets oxytocin receptor expression and may lead to ways to identify and treat people with autism. Read the news release here.
Several news agencies including ABC news and MSN Health and Fitness have covered the breakthrough nationally.
-
Sarah Nelson describes CHG Chiari Research. The CHG is poised to begin a promising research agenda aimed at discovering the genetic cause of Chiari Type I Malformation. Read the article here.
-
In May 2009, Dr. Terri Young was honored as a Silver Fellow by the Association for Research in Vision and Ophthalmology (ARVO) for her accomplishments, leadership and contributions to the association. As a fellow, the association anticipates she will continue to advance vision disorder research, prevention and cure. She is also expected to continue to serve as a role model and mentor of individuals pursuing careers in vision and ophthalmology research.
Additionally, Dr. Young was named a top physician mentor by the American Medical Association Women Physicians Congress. The award recognizes physician mentors who make a difference in the professional life of another physician.
-
Gene Variation May Lead to Early Cardiovascular Disease.
CHG Researchers have implicated variations in a gene that increases a person's susceptibility for early onset cardiovascular disease.
Article in PLoS Genetics
Duke Press Release
-
CHG Faculty member, Svati Shah, M.D., teams up with Duke cardiologists
to study the genetics of cardiac sudden death.
The study is discussed on page 8
The Abstract,, a Duke publication.
-
CHG Faculty member Simon Gregory was interviewed by
WebMD about MS genetic discoveries.
- Dr. Michelle Winn receives prestigious PECASE award.
The Presidential Early Career Award for Scientists and Engineers
is the highest honor bestowed by the U.S. government on outstanding
scientists and engineers beginning their independent careers.
The Presidential Awards are intended to recognize and nurture
those who, while early in their research careers, show exceptional
potential for leadership at the frontiers of scientific knowledge .
CHG faculty member Dr. Michelle Winn was a 2006 PECASE recipient.
// top //
|
|
